Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:40 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1057–1080 of 2,005 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Discrete Clear all

Conditions: Multiple Sclerosis, Alzheimer's Disease
Interventions: [F-18]PBR06, [C-11]PBR28; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 85 Years
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV, Non-small Cell Lung Cancer Metastatic
Interventions: Docetaxel, Combination of ganetespib and docetaxel; Drug
Lead sponsor: Synta Pharmaceuticals Corp.; Industry
Eligibility: 18 Years and older
Enrollment: 385 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 8
States / cities: Tucson, Arizona • Santa Monica, California • Atlanta, Georgia + 5 more

Conditions: Endothelial Dysfunction, Inflammation, Oxidative Stress
Interventions: Traditional hookah smoking, Electronic hookah vaping; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 21 Years to 39 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Atrial Fibrillation, Mitral Valve Insufficiency, Mitral Valve Stenosis
Interventions: MVS, Ablation; Procedure · Device
Lead sponsor: Annetine Gelijns; Other
Eligibility: 18 Years and older
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 18
States / cities: New Haven, Connecticut • Newark, Delaware • Atlanta, Georgia + 14 more

Conditions: Adenocarcinoma of Pancreas
Interventions: Replicative Adenovirus Vector (RGDCRAdCOX2F); Biological
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Nervous System Diseases, Diagnostic Imaging
Interventions: Ferumoxytol; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 255 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2021
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Focal Epilepsy
Interventions: Lu AG06466, Placebo; Drug
Lead sponsor: H. Lundbeck A/S; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cognitive Impairment, Creativity
Interventions: Musical arts intervention; Behavioral
Lead sponsor: William Marsh Rice University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Intradialytic Hypotension, End Stage Renal Disease, Low Blood Pressure
Interventions: ITD, Sham; Device
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 8 Years to 18 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Disease, Arthritis, Uterine Diseases, Spinal Diseases, Preventive Health Services
Interventions: Enhanced Support, Usual-Support; Behavioral
Lead sponsor: Health Dialog; Industry
Eligibility: Not listed
Enrollment: 174,120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Portland, Maine

Conditions: Pulmonary TB
Interventions: Obtain standard three daily sputum samples vs. three samples on the first day for the diagnosis of pulmonary TB.; Procedure
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy, Young Adults
Interventions: RLIC - 5 cycles, RLIC - 4 Cycles, RLIC - 3 Cycles, Sham conditioning, Balance training, Arm training, Sequence production training; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 40 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Chronic Low Back Pain
Interventions: Control, Education; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois • Seattle, Washington

Conditions: Pain
Interventions: 30-gauge needle, 32-gauge needle; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 25 Years to 70 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Epilepsy, Epilepsy in Children, Epilepsy; Seizure, Disease, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Epileptic Syndromes
Interventions: XEN496, Placebo; Drug
Lead sponsor: Xenon Pharmaceuticals Inc.; Industry
Eligibility: 1 Month to 6 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 11
States / cities: Orange, California • San Francisco, California • Aurora, Colorado + 8 more

Conditions: Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Colon, Signet Ring Adenocarcinoma of the Rectum, Stage IV Colon Cancer, Stage IV Rectal Cancer
Interventions: aflibercept, oxaliplatin, leucovorin, fluorouracil, Correlative Studies, DCE MRI, f18FDG-PET, PET (positron emission tomography); Biological · Drug · Other + 2 more
Lead sponsor: John Hays; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2022
U.S. locations: 6
States / cities: Ann Arbor, Michigan • Buffalo, New York • The Bronx, New York + 3 more

Conditions: Purpura, Thrombocytopaenic, Idiopathic
Interventions: Eltrombopag; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Advanced Solid Tumors, Relapsed/Refractory Lymphoma
Interventions: Alisertib, Itraconazole; Drug
Lead sponsor: Millennium Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 4
States / cities: St Louis, Missouri • Oklahoma City, Oklahoma • Germantown, Tennessee + 1 more

Conditions: Influenza
Interventions: Influenza Virus Vaccine, Monovalent A/H5N1 A/Indonesia/05/2005; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 64 Years
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Granular Dystrophy, Corneal
Interventions: Nd:YAG Laser; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Polycystic Ovary Syndrome, Healthy, Anovulation, Hyperandrogenism
Interventions: Recombinant Follicle Stimulating Hormone; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 37 Years · Female only
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Plague, Plague, Bubonic, Plague, Pneumonic, Yersinia Pestis Plague, Yersinia Pestis; Bubo, Yersinia Pestis; Pneumonia, Yersinia Sepsis, Yersinia Pestis Infection, Bubo; Yersinia Pestis, Bubonic; Plague, Skin, Pneumonic Plague
Interventions: Lateral Flow Assay for Pathogens of the Plague; Diagnostic Test
Lead sponsor: Brimrose Technology Corporation; Industry
Eligibility: 5 Years to 75 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: San Diego, California

Conditions: Amputation, Prostheses and Implants
Interventions: Intramuscular electrodes; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 75 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Pancreatic Cancer
Interventions: CART-meso-19 T cells, Cyclophosphamide; Biological · Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer

The Cardiovascular Effects of Electronic Hookah Vaping

Surgical Ablation Versus No Surgical Ablation for Patients With Atrial Fibrillation Undergoing Mitral Valve Surgery

Adenovirus (RGDCRAdCOX2F)

MR, Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System (CNS) Inflammation

A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy

Cognitive Health Research on Musical Arts

Application of Impedance Threshold Device Technologies to Treat and Prevent Hypotension During Dialysis

Deep Dive Randomized Control Trial

Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb

Effect of Number of Remote Limb Ischemic Conditioning Cycles on Learning Enhancement

The Ability of Chronic Pain Patients to Self-diagnose Their Chief Source of Low Back Pain

A Pilot Study of Needle Size and Pain Perception With Botulinum Toxin A Injections

XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect

A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory Lymphoma

Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 Vaccines

Neodymium-doped Yttrium Aluminum Garnet (Nd:YAG) Laser Treatment for Granular Corneal Dystrophy

Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS

Yersinia Pestis Lateral Flow Immunoassay for Blood Samples

Regenerative Peripheral Nerve Interface for Control of Lower Limb Prostheses

Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer